
1. j trop med hyg. 2013 may;88(5):828-34. doi: 10.4269/ajtmh.11-0795. epub 2013
mar 18.

association prevalence chloroquine resistance unusual mutation 
pfmdr-i pfcrt genes india.

das s(1), chakraborty sp, hati ak, roy s.

author information: 
(1)immunology microbiology laboratory, department human physiology with
community health, vidyasagar university, midnapore, west bengal, india.
sdas.vu@gmail.com

this study deals underlying causes failure chloroquine the
treatment plasmodium falciparum infection malaria-endemic regions of
india. samples collected 141 patients purulia march 2007 
april 2008. vitro drug susceptibility tests, parasitic dna isolation
followed polymerase chain reaction, restriction fragment-length
polymorphisms different codons pfcrt gene (76) pfmdr-i genes (86,
1042, 1246) assessed. responses 141 patients chloroquine 
determined. prevalence double pfmdr-i (58.16%) mutation (86y+1246y) some
(14.89%) single pfcrt mutations triple pfmdr-i mutation
(76t+86y+1042d+1246y) found. interestingly, double pfmdr-i mutation (86y and
1246y codons) observed early treatment failure cases. results 
show, first time india vitro chloroquine resistance in
vivo chloroquine treatment failure caused double pfmdr-i (p < 0.001)
mutation.

doi: 10.4269/ajtmh.11-0795 
pmcid: pmc3752744
pmid: 23509121  [indexed medline]

